Selected research
Market Structure
Global Pharmaceutical Grade Poloxamer 407 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Grade Poloxamer 407 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharmaceutical Grade Poloxamer 407 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Grade Poloxamer 407 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Grade Poloxamer 407 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Grade Poloxamer 407 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Grade Poloxamer 407 include BASF, Croda, Comercial Química Massó, CD Formulation and Solvay, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Pharmaceutical Grade Poloxamer 407 output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Pharmaceutical Grade Poloxamer 407 by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Pharmaceutical Grade Poloxamer 407 market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Grade Poloxamer 407 and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Grade Poloxamer 407 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade Poloxamer 407 market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Grade Poloxamer 407 Segment by Company
BASF
Croda
Comercial Química Massó
CD Formulation
Solvay
Pharmaceutical Grade Poloxamer 407 Segment by Type
Flakes
Powder
Pharmaceutical Grade Poloxamer 407 Segment by Application
Topical Formulations
Oral Care Formulations
Solid Dosage Forms
Pharmaceutical Grade Poloxamer 407 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Poloxamer 407 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Poloxamer 407 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Poloxamer 407.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharmaceutical Grade Poloxamer 407 market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Grade Poloxamer 407 industry.
Chapter 3: Detailed analysis of Pharmaceutical Grade Poloxamer 407 market competition landscape. Including Pharmaceutical Grade Poloxamer 407 manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Pharmaceutical Grade Poloxamer 407 by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Pharmaceutical Grade Poloxamer 407 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Flakes
- Powder
Applications
- Topical Formulations
- Oral Care Formulations
- Solid Dosage Forms
Companies covered
- BASF
- Croda
- Comercial Química Massó
- CD Formulation
- Solvay
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pharmaceutical Grade Poloxamer 407 Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pharmaceutical Grade Poloxamer 407 Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Pharmaceutical Grade Poloxamer 407 Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Pharmaceutical Grade Poloxamer 407 Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Pharmaceutical Grade Poloxamer 407 Market Dynamics
- 2.1 Pharmaceutical Grade Poloxamer 407 Industry Trends
- 2.2 Pharmaceutical Grade Poloxamer 407 Industry Drivers
- 2.3 Pharmaceutical Grade Poloxamer 407 Industry Opportunities and Challenges
- 2.4 Pharmaceutical Grade Poloxamer 407 Industry Restraints
3 Pharmaceutical Grade Poloxamer 407 Market by Manufacturers
- 3.1 Global Pharmaceutical Grade Poloxamer 407 Production Value by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Grade Poloxamer 407 Production by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Grade Poloxamer 407 Average Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Grade Poloxamer 407 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Grade Poloxamer 407 Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Grade Poloxamer 407 Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Grade Poloxamer 407 Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharmaceutical Grade Poloxamer 407 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharmaceutical Grade Poloxamer 407 Players Market Share by Production Value in 2025
- 3.8.3 2025 Pharmaceutical Grade Poloxamer 407 Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Grade Poloxamer 407 Market by Type
- 4.1 Pharmaceutical Grade Poloxamer 407 Type Introduction
- 4.1.1 Flakes
- 4.1.2 Powder
- 4.2 Global Pharmaceutical Grade Poloxamer 407 Production by Type
- 4.2.1 Global Pharmaceutical Grade Poloxamer 407 Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Grade Poloxamer 407 Production by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Grade Poloxamer 407 Production Market Share by Type (2021-2032)
- 4.3 Global Pharmaceutical Grade Poloxamer 407 Production Value by Type
- 4.3.1 Global Pharmaceutical Grade Poloxamer 407 Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharmaceutical Grade Poloxamer 407 Production Value by Type (2021-2032)
- 4.3.3 Global Pharmaceutical Grade Poloxamer 407 Production Value Market Share by Type (2021-2032)
5 Pharmaceutical Grade Poloxamer 407 Market by Application
- 5.1 Pharmaceutical Grade Poloxamer 407 Application Introduction
- 5.1.1 Topical Formulations
- 5.1.2 Oral Care Formulations
- 5.1.3 Solid Dosage Forms
- 5.2 Global Pharmaceutical Grade Poloxamer 407 Production by Application
- 5.2.1 Global Pharmaceutical Grade Poloxamer 407 Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Grade Poloxamer 407 Production by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Grade Poloxamer 407 Production Market Share by Application (2021-2032)
- 5.3 Global Pharmaceutical Grade Poloxamer 407 Production Value by Application
- 5.3.1 Global Pharmaceutical Grade Poloxamer 407 Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharmaceutical Grade Poloxamer 407 Production Value by Application (2021-2032)
- 5.3.3 Global Pharmaceutical Grade Poloxamer 407 Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 BASF
- 6.1.1 BASF Company Information
- 6.1.2 BASF Business Overview
- 6.1.3 BASF Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2021-2026)
- 6.1.4 BASF Pharmaceutical Grade Poloxamer 407 Product Portfolio
- 6.1.5 BASF Recent Developments
- 6.2 Croda
- 6.2.1 Croda Company Information
- 6.2.2 Croda Business Overview
- 6.2.3 Croda Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2021-2026)
- 6.2.4 Croda Pharmaceutical Grade Poloxamer 407 Product Portfolio
- 6.2.5 Croda Recent Developments
- 6.3 Comercial Química Massó
- 6.3.1 Comercial Química Massó Company Information
- 6.3.2 Comercial Química Massó Business Overview
- 6.3.3 Comercial Química Massó Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2021-2026)
- 6.3.4 Comercial Química Massó Pharmaceutical Grade Poloxamer 407 Product Portfolio
- 6.3.5 Comercial Química Massó Recent Developments
- 6.4 CD Formulation
- 6.4.1 CD Formulation Company Information
- 6.4.2 CD Formulation Business Overview
- 6.4.3 CD Formulation Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2021-2026)
- 6.4.4 CD Formulation Pharmaceutical Grade Poloxamer 407 Product Portfolio
- 6.4.5 CD Formulation Recent Developments
- 6.5 Solvay
- 6.5.1 Solvay Company Information
- 6.5.2 Solvay Business Overview
- 6.5.3 Solvay Pharmaceutical Grade Poloxamer 407 Production, Value and Gross Margin (2021-2026)
- 6.5.4 Solvay Pharmaceutical Grade Poloxamer 407 Product Portfolio
- 6.5.5 Solvay Recent Developments
7 Global Pharmaceutical Grade Poloxamer 407 Production by Region
- 7.1 Global Pharmaceutical Grade Poloxamer 407 Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Pharmaceutical Grade Poloxamer 407 Production by Region (2021-2032)
- 7.2.1 Global Pharmaceutical Grade Poloxamer 407 Production by Region (2021-2026)
- 7.2.2 Global Pharmaceutical Grade Poloxamer 407 Production Forecast by Region (2027-2032)
- 7.3 Global Pharmaceutical Grade Poloxamer 407 Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Pharmaceutical Grade Poloxamer 407 Production Value by Region (2021-2032)
- 7.4.1 Global Pharmaceutical Grade Poloxamer 407 Production Value by Region (2021-2026)
- 7.4.2 Global Pharmaceutical Grade Poloxamer 407 Production Value by Region (2027-2032)
- 7.5 Global Pharmaceutical Grade Poloxamer 407 Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Pharmaceutical Grade Poloxamer 407 Production Value (2021-2032)
- 7.6.2 Europe Pharmaceutical Grade Poloxamer 407 Production Value (2021-2032)
- 7.6.3 Asia-Pacific Pharmaceutical Grade Poloxamer 407 Production Value (2021-2032)
- 7.6.4 South America Pharmaceutical Grade Poloxamer 407 Production Value (2021-2032)
- 7.6.5 Middle East & Africa Pharmaceutical Grade Poloxamer 407 Production Value (2021-2032)
8 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region
- 8.1 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region (2021-2032)
- 8.2.1 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region (2021-2026)
- 8.2.2 Global Pharmaceutical Grade Poloxamer 407 Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Pharmaceutical Grade Poloxamer 407 Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Pharmaceutical Grade Poloxamer 407 Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Pharmaceutical Grade Poloxamer 407 Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Pharmaceutical Grade Poloxamer 407 Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Pharmaceutical Grade Poloxamer 407 Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Pharmaceutical Grade Poloxamer 407 Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Pharmaceutical Grade Poloxamer 407 Value Chain Analysis
- 9.1.1 Pharmaceutical Grade Poloxamer 407 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharmaceutical Grade Poloxamer 407 Production Mode & Process
- 9.2 Pharmaceutical Grade Poloxamer 407 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Grade Poloxamer 407 Distributors
- 9.2.3 Pharmaceutical Grade Poloxamer 407 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst